Pyoderma gangrenosum (PG) is a difficult-to-treat inflammatory skin condition that affects inflammatory bowel disease (IBD) patients. There is no standardized approach for PG treatment. We report the results of 3 patients with Crohn's disease (CD) and refractory PG who had failed several therapies with biologics and were started on tofacitinib for severe inflammatory arthritis with resolution of their PG.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cgh.2018.10.047 | DOI Listing |
Publication Analysis
Top Keywords
pyoderma gangrenosum
8
tofacitinib treatment
4
treatment pyoderma
4
gangrenosum pyoderma
4
gangrenosum difficult-to-treat
4
difficult-to-treat inflammatory
4
inflammatory skin
4
skin condition
4
condition inflammatory
4
inflammatory bowel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!